Inactive Instrument

All News Sartorius Stedim Biotech SA Euronext Paris

Equities

STDM

FR0000053266

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

09:49am	U.S. Futures, European Stocks Rise	DJ
08:25am	Sartorius Stedim: Quarterly EPS more than halved	CF

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

U.S. Futures, European Stocks Rise	03:49am	DJ
Sartorius Stedim: Quarterly EPS more than halved	02:25am	CF
Sartorius Stedim Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	02:08am	CI
Sartorius Stedim Biotech Records Lower Q1 Attributable Net Profit, Sales Revenue	01:41am	MT
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024	01:04am	EQ
Ex-dividend day for final dividend	Apr. 01	FA
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.	Mar. 26	EQ
Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call	Mar. 26
SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating	Mar. 12	ZD
Berenberg: Sartorius Stedim Investors Await 'Several Strong Quarters' for Confidence Boost	Feb. 16	MT
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	Feb. 16	EQ
Sartorius Stedim Biotech releases Universal Registration Document 2023	Feb. 16	EQ
Sartorius Stedim Biotech: Information on Document Availability	Feb. 16	EQ
Sartorius gains despite halving dividend	Feb. 09	DP
Sartorius Stedim Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
Sartorius Stedim: dividend set for 2023	Feb. 08	CF
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting	Feb. 07	EQ
Dpa-AFX Overview: COMPANIES from 07.02.2024 - 15:15	Feb. 07	DP
Debt reduction: Sartorius sells shares - Stedim with capital increase	Feb. 07	DP
Sartorius Stedim Biotech Shares Fall After Capital Increase	Feb. 07	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SARTORIUS STEDIM BIOTECH : FY23: Updated mid-term outlook offers much-valued ‘certainty’

January 30, 2024 at 11:54 am EST